Jorge Mutis (@JorgeMutis3) profile picture

Neurologist @URosario. Neurovascular and neurointeventionist @Angio_team. 📍Colombia.

Medellín, Colombia
Joined August 2020
Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)Photo by Jorge Mutis (@JorgeMutis3)
Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke: @NEJM 🥸 Advances in neuro-interventions: LATE-MT trial 😱Summary 👇👇👇
1
54
2
150
13,394
Jorge Mutis retweeted
Karl Deisseroth, MD, PhD, winner of the Nobel Prize in Physiology or Medicine 2026, describes the science behind a study of intravitreal delivery of an AAV vector encoding a light-gated ion channel in 10 blind patients with advanced retinitis pigmentosa. Read the editorial “Optogenetics in Sight”: nej.md/476T5x1
6
201
3
601
37,168
Jorge Mutis retweeted
Orgullo para la Psiquiatría y las Neurociencias 🧠. Karl Deisseroth, psiquiatra y bioingeniero de Stanford, comparte el Premio Nobel de Fisiología o Medicina 2026 con Peter Hegemann y Georg Nagel por el desarrollo de la optogenética, una técnica que usa proteínas sensibles a la luz (originalmente descubiertas en algas) para activar o silenciar neuronas específicas en el cerebro vivo con precisión milisegundos. Para la psiquiatría esto representa un salto histórico: por primera vez un clínico formado en el diagnóstico y tratamiento de trastornos mentales lidera una herramienta que permite estudiar de forma causal los circuitos que subyacen a la depresión, la ansiedad, la adicción o la psicosis, en lugar de limitarse a correlaciones o modelos animales imprecisos. La optogenética ya ha mapeado vías neuronales relacionadas con el estado de ánimo, la motivación y la memoria, y abre la puerta a terapias más dirigidas, desde la estimulación cerebral selectiva hasta posibles aplicaciones en enfermedades oftalmológicas con componente neurológico, acercando la especialidad a una comprensión mecanicista del cerebro que puede traducirse en intervenciones más efectivas y menos empíricas.
2026 #NobelPrize laureate in physiology or medicine Karl Deisseroth was born in 1971. He received his Ph.D. and MD from @Stanford University, USA. He is currently D.H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences, at the Howard Hughes Medical Institute and Stanford University, USA. med.stanford.edu/profiles/ka… #NobelPrize
7
76
375
8,092
#MondayTip #IAthrombolysis 🧠Successful EVT ≠ complete tissue reperfusion 💉Adjunct IAT may improve excellent outcomes in selected anterior-circulation LVO ⚖️But trials remain mixed & mortality/disability benefit is unproven 🗝️Patient selection is key doi.org/10.1161/STROKEAHA.12…
31
57
2,660
Just Published Factors Associated with Aneurysm Occlusion after Flow Diverter Treatment doi.org/10.5797/jnet.ra.2026… #Neuroendovascular
8
1
20
2,117
Jorge Mutis retweeted
Es un genio el 10 de España, podes pedirle que presione, que filtre pases, que haga goles e incluso que tire centros. Lo único que no podes es pedirle peras.
64
412
12
11,964
243,313
Hydration Break 1994 😂
79
1,743
102
13,592
1,986,654
In a new @NatureNeuro study led by @UCSF neurosurgeon @EWinklerMDPhD, researchers profiled the cells in human aneurysms, identifying the changes that make a rupture more likely and new opportunities for therapeutic intervention: nature.com/articles/s41593-0… @mtlawton @BarrowNeuro
24
1
58
4,827
Jorge Mutis retweeted
47
3,186
49
47,893
343,182
Jorge Mutis retweeted
𝗚𝗢𝗔𝗧 𝘇𝘂𝗿𝘂̈𝗰𝗸 𝗶𝗺 𝗧𝗼𝗿 𝗳𝘂̈𝗿 𝗗𝗲𝘂𝘁𝘀𝗰𝗵𝗹𝗮𝗻𝗱! 🐐 Manu steht wieder zwischen den Pfosten. 🙌
26
156
12
2,706
44,693
People are all over the place on whether or not to treat MVO strokes. Here is a nice study showing benefit with EVR. Although this single paper may not sway practice immediately, it will help the inevitable progression towards treating MVO strokes with intervention. The main impetus for this will be the continued expansion of thrombectomy capable centers — and further proliferation of Neuro endovascular specialists. Endovascular Treatment of Medium-Vessel-Occlusion Strokes | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
17
40
2,958
DISTALS trial shows improved reperfusion with Tigertriever device in MeVO patients. No definite impact on clinical outcome, but stroke severity was relatively mild #ESOC2026 @svinsociety
2
13
24
1,767
Jorge Mutis retweeted
Could targeting the middle meningeal artery help reduce headache and opioid use after aneurysmal subarachnoid hemorrhage? In this JNIS pilot study, MMA infusion of lidocaine ± dexamethasone during aneurysm embolization was associated with reduced pain burden, lower opioid use, and no complications in patients with low-grade aSAH. @PeterKa80460001 @utmbhealth @UTMBNeurosurg @DrHongTao Read more: bit.ly/3OZgScN
1
19
1
49
3,791
Jorge Mutis retweeted
🧠 Radial first in neurointervention continues to grow. In this multicenter European study, the Benchmark BMX81 showed high technical success (96.3%) with low crossover to femoral access and few mostly minor access-related complications. @VCostalat 📖 Read more: bit.ly/4ss6jww
1
16
1
41
3,398
Jorge Mutis retweeted
La tripulación de Artemis II capturó esta mañana una imagen impresionante de la Tierra desde 41.000 millas de distancia. Es la primera vez desde 1972 que los seres humanos ven una Tierra en fase creciente en su totalidad.
85
2,154
112
19,010
287,734
Jorge Mutis retweeted
Liftoff. The Artemis II mission launched from @NASAKennedy at 6:35pm ET (2235 UTC), propelling four astronauts on a journey around the Moon. Artemis II will pave the way for future Moon landings, as well as the next giant leap — astronauts on Mars.
3,727
53,906
7,157
174,618
14,435,624